Harry completed an integrated Master’s degree in biology at Durham University before joining Cancer Research UK in November 2018. He’s currently studying a Master’s in science communication at Imperial College London part-time alongside his role as a science media officer, where he works on getting media coverage of the great research Cancer Research UK funds.
There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.
LGBTQ+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQ+ people.
A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.
Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.
Our scientists are using hydrogels to understand more about how pancreatic cancer cells spread.
Scientists have developed an entirely new way to look at tumours. And it’s helped them solve the mystery of how some pancreatic tumours develop.